These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Randomized, double-blind, placebo-controlled trial of the 5-HT1A receptor antagonist AZD7371 tartrate monohydrate (robalzotan tartrate monohydrate) in patients with irritable bowel syndrome. Drossman DA; Danilewitz M; Naesdal J; Hwang C; Adler J; Silberg DG Am J Gastroenterol; 2008 Oct; 103(10):2562-9. PubMed ID: 18775020 [TBL] [Abstract][Full Text] [Related]
11. Clinical trial: the efficacy of alverine citrate/simeticone combination on abdominal pain/discomfort in irritable bowel syndrome--a randomized, double-blind, placebo-controlled study. Wittmann T; Paradowski L; Ducrotté P; Bueno L; Andro Delestrain MC Aliment Pharmacol Ther; 2010 Mar; 31(6):615-24. PubMed ID: 20003095 [TBL] [Abstract][Full Text] [Related]
12. Nucleotide supplementation: a randomised double-blind placebo controlled trial of IntestAidIB in people with Irritable Bowel Syndrome [ISRCTN67764449]. Dancey CP; Attree EA; Brown KF Nutr J; 2006 Jun; 5():16. PubMed ID: 16762076 [TBL] [Abstract][Full Text] [Related]
13. A randomized, double-blind, placebo-controlled multicenter trial of saccharomyces boulardii in irritable bowel syndrome: effect on quality of life. Choi CH; Jo SY; Park HJ; Chang SK; Byeon JS; Myung SJ J Clin Gastroenterol; 2011 Sep; 45(8):679-83. PubMed ID: 21301358 [TBL] [Abstract][Full Text] [Related]
14. VSL#3 improves symptoms in children with irritable bowel syndrome: a multicenter, randomized, placebo-controlled, double-blind, crossover study. Guandalini S; Magazzù G; Chiaro A; La Balestra V; Di Nardo G; Gopalan S; Sibal A; Romano C; Canani RB; Lionetti P; Setty M J Pediatr Gastroenterol Nutr; 2010 Jul; 51(1):24-30. PubMed ID: 20453678 [TBL] [Abstract][Full Text] [Related]
15. Randomized clinical trial: effect of Lactobacillus plantarum 299 v on symptoms of irritable bowel syndrome. Stevenson C; Blaauw R; Fredericks E; Visser J; Roux S Nutrition; 2014 Oct; 30(10):1151-7. PubMed ID: 25194614 [TBL] [Abstract][Full Text] [Related]
16. A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6-month intervention. Kajander K; Hatakka K; Poussa T; Färkkilä M; Korpela R Aliment Pharmacol Ther; 2005 Sep; 22(5):387-94. PubMed ID: 16128676 [TBL] [Abstract][Full Text] [Related]
17. How can we achieve relief of bowel and abdominal symptoms for patients with irritable bowel syndrome with constipation? Tack J Expert Rev Gastroenterol Hepatol; 2013 Jul; 7(5 Suppl 1):21-6. PubMed ID: 23859757 [TBL] [Abstract][Full Text] [Related]
18. A randomized, double-blind, placebo-controlled trial of St John's wort for treating irritable bowel syndrome. Saito YA; Rey E; Almazar-Elder AE; Harmsen WS; Zinsmeister AR; Locke GR; Talley NJ Am J Gastroenterol; 2010 Jan; 105(1):170-7. PubMed ID: 19809408 [TBL] [Abstract][Full Text] [Related]
19. A Randomized Clinical Trial of Berberine Hydrochloride in Patients with Diarrhea-Predominant Irritable Bowel Syndrome. Chen C; Tao C; Liu Z; Lu M; Pan Q; Zheng L; Li Q; Song Z; Fichna J Phytother Res; 2015 Nov; 29(11):1822-7. PubMed ID: 26400188 [TBL] [Abstract][Full Text] [Related]
20. Double-blind placebo-controlled trial of amitriptyline for the treatment of irritable bowel syndrome in adolescents. Bahar RJ; Collins BS; Steinmetz B; Ament ME J Pediatr; 2008 May; 152(5):685-9. PubMed ID: 18410774 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]